Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
this study amis to assess the incidence and severity of liver dysfunction in ITP patients receiving eltrombopag.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
Locations
Other Locations
Egypt
Sohag university hospital
RECRUITING
Sohag
Contact Information
Primary
Peter A Alfy, Resident
peter.adel.dola@gmail.com
01274069691
Backup
Usama M Abdelaal, Professor
01065962094
Time Frame
Start Date: 2025-07-14
Estimated Completion Date: 2026-01-20
Participants
Target number of participants: 100
Treatments
Experimental: this group will receive Eltrombopag tabelts
ITP patients in this group receive Eltrombopag then follow up by liver functions test to evulate occurance of liver disorders .
Related Therapeutic Areas
Sponsors
Leads: Sohag University